LAKE FOREST, Calif.--(BUSINESS WIRE)--March 6, 2002



Biozhem Cosmeceuticals Inc. (OTCBB:BZHM) a developer and marketer of advanced skin care products, today announced that its Chairman and CEO, James S. Chapin, is being featured in an online interview at CEOcast.com.



In the interview, Chapin discusses the ongoing excellent results from Biozhem's nationally airing infomercial featuring Emmy(R) award-winning actress Lindsay Wagner. He also describes Biozhem's plans to sell its products through additional channels and expresses optimism that the company will become profitable over the near term.



Chapin stated: "Our RevitaCel Replenishing Complex is a biotechnology breakthrough for rejuvenating aging and sun-damaged skin. Our results to date and our optimism about our future are derived from the paradigm shift in skin care that our products represent."



Biozhem's Replenishing Complex contains the NouriCel(TM) ingredient, the first and only cosmetic ingredient derived from a patented process for growing human fibroblast-derived skin substitutes for treating serious burns and wounds, and bioengineered collagen for other conditions. As the tissue-engineered products grow, they produce an array of natural growth factors, antioxidants, matrix proteins and soluble collagens -- all compounds naturally produced by healthy new skin, but which aging skin can no longer make.



After the tissue-engineered products are collected, a nutrient solution enriched with these compounds remains. This solution, which does not contain any cells, is the NouriCel ingredient.



A link to the interview is available at http://www.ceocast.com. In addition to the television offer, the products are available through Biozhem's Customer Care Center at 800/535-1007.



Biozhem has the exclusive global rights to NouriCel for the direct response market. The company intends sell the RevitaCel System and its other premium quality skin care products for women and men through infomercials, home shopping channels, the Internet, and other direct response channels on a global basis.



Statements about the company's future expectations and all other statements in this news release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that is defined in the Private Litigation Reform Act of 1995. The company intends that such forward-looking statements be subject to the safe harbor created thereby. Since these statements involve risks and uncertainties and are subject to change at any time, the company's actual results could differ materially from expected results.